Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

AzPA Anticoagulation Certificate Program


AzPA Anticoagulation Certificate Program

ACPE UAN: 0100-0000-15-086-B01-P
Friday, January 19, 2018
Midwestern University College of Pharmacy 
19555 N. 59th Avenue
Glendale, AZ  85308
Cholla Hall Room 116-118
 
OVERVIEW:

This certificate program is a comprehensive program designed to provide pharmacists with the basic knowledge and skills necessary to care for patients taking anticoagulation therapies. By completing this course, pharmacists can earn 22 hours of continuing education credit while becoming certified in anticoagulation management. The Anticoagulation Certificate Program is conducted in two parts: the self-study and live training seminar. To earn a certificate of achievement, participants must successfully complete all components of the program.

 

PROGRAM OUTCOME: 

With expanded use of anticoagulant agents, the number of patients receiving these drugs has increased dramatically. Safe and effective anticoagulation must include a number of key components to avoid complications. These include careful patient assessment, an understanding of the clotting cascade and mechanisms of action of anticoagulant therapies, a detailed focus on factors which influence therapy and knowledge of current guidelines. This certificate program is a comprehensive program designed to provide pharmacists with the basic knowledge and skills necessary to care for patients taking anticoagulation therapies. By completing this course, pharmacists can earn 22 contact hours of continuing pharmacy education credit while becoming certified in anticoagulation management. 

 

HOME STUDY LEARNING OBJECTIVES:

  1. Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
  2. Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
  3. Recognize strategies used to manage hemorrhagic complications and HIT associated with anticoagulant therapy
  4. Identify appropriate methods to manage antithrombotic therapy during the perioperative time period
The home study portion will be composed of nine separate modules. The required reading pages will be displayed in each module along with corresponding study guide questions which are to be completed and collected at the live CE program. Please write your answers in the spaces provided, feel free to use as much space as needed to fully answer each question. For the multiple choice, True/False and choose the correct answer questions, please circle or highlight your choice in the space provided within each question. After completing each of the sections, you will be required to complete the Home Study Examination for that module before moving on to the next one. You need to score a 70% or better to pass. Learners are eligible for 14 HOURS HOME-STUDY/ 1.4 CEUs) application-based learning activity 

 

LIVE SEMINAR LEARNING OBJECTIVES: 

  1. Review pathophysiology of thrombosis
  2. Describe the difference in mechanism of action between the new and old antithrombotic therapies
  3. Describe the indications for anticoagulation therapy
  4. Review current treatment guidelines
  5. Evaluate the initiation and dosing of warfarin
  6. Determine factors influencing dosing of warfarin and the appropriate management of out-of-range INRs
  7. Develop assessment tools which account for variables impacting warfarin intensity and dosing
  8. Compare and contrast available point of care devices for anticoagulation therapies and demonstrate correct patient care procedures for testing
  9. Evaluate ‘bridging” therapies for anticoagulation management
  10. Practice assessing patients on anticoagulation therapies through the use of patient cases
The live program involves 8.0 contact hours (0.80 CEUs) of both lecture and simulation training. Participants will focus on the pathophysiology of thrombosis, receive an overview of ACCP Guidelines, discuss indications for anticoagulation therapy, warfarin dosing and monitoring, management of the over-anticoagulated patient and patients requiring procedure management, patient education, and patient interviewing and assessment. Participants will also learn about point-of care monitoring devices, and practice assessing patients through the use of patient cases. At the conclusion of the live program each participant must complete the on-line final exam with a score of 70% or above and a program evaluation in order to receive a certificate of completion. Pharmacists will receive a total of 8.0 contact hours or 0.8 CEUs of continuing pharmacy education for completion of this component. Learners are eligible for 8 HOURS LIVE/ 0.8 CEUs) application-based learning activity 
 
PROGRAM FACULTY: 
  • Lindsay Davis, Pharm.D., FAzPA. BCPS
  • Kayla Kloc, Pharm.D., CACP
  • Elizabeth Pogge, Pharm.D., MPH, BCPS, FASCP
  • Elizabeth Palmer, PharmD

 

Program Fees Early Bird Rates until 12/31/2017* Regular rates after 12/31/2017*
AzPA Member Pharmacist
$350 $400
Non-Member Pharmacist
$450 $500
AzPA Member Student
$250 $300
Non-Member Student
$350 $400

*Use Coupon Code: anticoag119 to get early bird rates

CONTINUING PHARMACY EDUCATION CREDIT AND ACTIVITY REQUIREMENTS: The Anticoagulation Certificate Program has been approved for 22.0 contact hours or (2.20 CEUs). 

  • ACPE UAN 0100-0000-15-086-B01-P
  • Initial Release Date: 11/21/2015 Planned Expiration Date: 11/21/2018
  • Activity Type:  Practice-based
  • Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
  • Target Audience:  Pharmacists in all practice settings 

ACTIVITY COMPLETION REQUIREMENTS:

  • A Certificate of Achievement is awarded to participants who successfully complete all activity requirements, which include the self assessments, the home-study activity, the home-study exam, the live training seminar, and the final exam and evaluation. The self-study materials must be completed prior to the live session on Friday, January 19, 2018. The final exam and evaluation must be completed no later than February 19, 2018. We will upload all credits 30 days from the live session date. It is the participants responsibility to ensure your credits are uploaded within 60 days from the live session date. After this time you will no longer be able to claim your CPE credit.
    • Successful completion of the home-study component involves passing the home-study exam with a grade of 70% or higher and will result in 14.0 contact hours of CPE credits (1.40 CEUs). 
    • Successful completion of the live seminar component involves attending the full live seminar, passing the final exam with a grade of 70% or higher and completing a final evaluation. Successful completion of this component will result in 8.0 contact hours of CPE credit (0.80 CEUs). 

REFUND POLICY:

  • Refund and/or cancellation requests must be made in writing to the Arizona Pharmacy Association office. A cancellation request must be made at least fourteen calendar days prior to the scheduled program will be charged a $100.00 fee. No refunds will be issued for cancellation requests made less than fourteen calendar days prior to the scheduled program. You must submit a written request to cancel by email, fax, or standard mail and confirm that AzPA has received the request. AzPA reserves the right to cancel any activity due to insufficient pre-registration or as determined by the Executive Director or Operations Director. In this case, all individuals pre-registered are notified and issued a full refund. Registration fees cannot be re-allocated due to the multiple steps involved with processing CE Credits. Refund checks will be mailed fourteen business days after the conclusion of the meeting, if approved.

 

Date: Jan 19, 2018 08:00 AM - 05:00 AM

CE Hours

22.00

CE Units

2.200

Registration closes on Jan 17, 2018 12:00 AM

Target Audience(s)

  • Pharmacists
  • Student

Accreditation(s)

Accreditation Council for Pharmacy Education
The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.

 

 

 

   

Module 1:  Venous and Arterial Thrombosis
  
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period
 

   

   

Module 2:  Venous and Arterial Thrombosis
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Module 3:  Oral Anticoagulant Therapy
 
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Module 4:  Oral Anticoagulant Therapy
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period
     

   

   

Module 5:  Antithrombotic Therapy for Venous Thromboembolic Disease 
 
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Module 6:  Antithrombotic Therapy in Atrial Fibrillation
 
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Module 7:  Valvular Heart Disease
 
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Module 8:  Perioperative Management of Antithrombotic Therapy
 
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Module 9:  Antithrombotic Reversal
 
At the completion of this home-study program, the participant should be able to:
 
1.  Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
2.  Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
3.  Recognize strategies used to manage hemmorhagic complications and HIT associated with anticoagulant therapy
4.  Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

   

   

Anticoagulation Certificate Program - Live Session
 
At the completion of this live program, the participant should be able to:
 
1.  Discuss the intimate connection between bleeding and clotting in the maintenance of circulatory hemostasis
2.  Explain key concepts of the coagulation cascade as they relate to the physiologic action of antithrombotic agents
3.  Identify risk factors for thrombus formation
4.  Differentiate the following therapeutic terms: antithrombotic  - anticoagulant  -antiplatelet
5.  Describe the pathophysiology of clot formation in arterial and  venous vasculature, including: venous thromboembolism, ischemic stroke (cardio and ncardioembolic
     sources), and acute coronary syndrome
6. Compare & contrast anticoagulants currently on the US market based on their mechanism of action (MOA) with a focus on the following parameters:
                 •  Passive vs. Active MOA
                 •  Indirect vs. Direct action on activated clotting factors (dependence on antithrombin to exert its anticoagulant effects) 

OBJECTIVES

1.

Discuss the intimate connection between bleeding and clotting in the

maintenance of circulatory hemostasis

2.

Explain key concepts of the coagulation cascade as they relate to the

physiologic action of antithrombotic agents

3.

Identify risk factors for thrombus formation

4.

Differentiate the following therapeutic terms:

- antithrombotic - anticoagulant -antiplatelet

5.

Describe the pathophysiology of clot formation in arterial and

venous

vasculature, including: throboembolism, ischemic stroke (cardio-

and noncardioembolic ), and acute coronary syndrome

6.

Compare & contrast anticoagulants currently on the US marke

t based on their

mechanism of action (MOA) with a focus on the following paramet

ers:

Passive vs. Active MOA

Indirect vs. Direct action on activated clotting factors (dependence on

antithrombin to exert its anticoagulant effects)

Activity Number

0100-0000-15-086-B01-P
Date: 01/19/18
Time: 08:00 AM - 05:00 PM

CE Hours

22.00